Table 2.

Cumulative incidence estimates of treatment initiation, transformation to DLBCL before treatment, and death without therapy based on the duration of W/W strategy.

Time from start of W/W	FL status	Likelihood (point estimates) in the next 1 year (95% CI)	Likelihood (point estimates) in the next 2 years (95% CI)	Likelihood (point estimates) in the next 5 years (95% CI)	Likelihood (point estimates) in the next 10 years (95% CI)
Diagnosis	Transformation prior to therapy	0.01 (0.00, 0.03)	0.03 (0.01, 0.05)	0.06 (0.04, 0.09)	0.09 (0.06, 0.13)
	Initiation of therapy	0.16 (0.13, 0.20)	0.26 (0.22, 0.31)	0.43 (0.38, 0.48)	0.48 (0.43, 0.54)
	Death without therapy	0.01 (0.00, 0.03)	0.02 (0.01, 0.04)	0.04 (0.03, 0.07)	0.06 (0.04, 0.10)
2 years	Transformation	0.02 (0.01, 0.04)	0.04 (0.02, 0.07)	0.06 (0.04, 0.10)	0.09 (0.06, 0.14)
	Therapy	0.10 (0.07, 0.14)	0.18 (0.14, 0.23)	0.30 (0.25, 0.37)	0.39 (0.32, 0.48)
	Death	0.01 (0.00, 0.03)	0.02 (0.01, 0.05)	0.04 (0.02, 0.07)	0.10 (0.06, 0.19)
4 years	Transformation	0.02 (0.01, 0.05)	0.03 (0.01, 0.07)	0.05 (0.03, 0.11)	0.09 (0.04, 0.19)
	Therapy	0.08 (0.05, 0.14)	0.13 (0.09, 0.19)	0.19 (0.14, 0.26)	0.36 (0.26, 0.50)
	Death	0.01 (0.00, 0.04)	0.02 (0.01, 0.05)	0.02 (0.02, 0.06)	0.17 (0.09, 0.33)
5 years	Transformation	0.01 (0.00, 0.05)	0.02 (0.01, 0.06)	0.06 (0.02, 0.13)	0.08 (0.04, 0.20)
	Therapy	0.05 (0.03, 0.10)	0.09 (0.05, 0.16)	0.12 (0.07, 0.19)	0.31 (0.20, 0.47)
	Death	0.01 (0.00, 0.05)	0.01 (0.00, 0.06)	0.04 (0.02, 0.11)	0.18 (0.09, 0.37)
6 years	Transformation	0.01 (0.00, 0.06)	0.02 (0.00, 0.07)	0.05 (0.02, 0.12)	0.08 (0.03, 0.21)
	Therapy	0.04 (0.02, 0.10)	0.07 (0.04, 0.14)	0.13 (0.07, 0.23)	0.28 (0.17, 0.45)
	Death	0.02 (0.00, 0.06)	0.02 (0.00, 0.05)	0.06 (0.02, 0.16)	0.19 (0.09, 0.39)